PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1324357
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1324357
According to Stratistics MRC, the Global Surgical Sutures Market is accounted for $4.88 billion in 2023 and is expected to reach $8.25 billion by 2030 growing at a CAGR of 7.8% during the forecast period. A surgical suture is a piece of medical equipment used to close wound edges after surgery or injury and hold body tissues together. Usually, a needle with a thread attached is used to apply it. The characteristics and location of the wound determine which suture should be used. Medical professionals take into account the thread's tensile strength, material, operator friendliness, and elasticity to hold tissues together successfully.
According to the World Health Organization (WHO), till February 2020, around 20-50 million people suffered from non-fatal injuries, of which some resulted in bone fractures, and have consecutively undergone ankle arthroplasty and other bone surgeries.
The use of this device to close wounds more quickly is increasing due to the rise in knee replacements, hip replacements, hysterectomy, bypass surgeries, and cosmetic surgeries. Additionally, the demand for and use of surgical sutures is being increased by the rapidly growing elderly population as a result of the rising frequency of surgical procedures like joint replacement, angioplasty, and organ transplant among elderly patients. This is causing healthcare facilities all over the world to demand more advanced devices.
Researchers are developing new technologies for patients' benefit, which has increased the number of minimally invasive procedures. These procedures are more affordable than open surgeries, offer better results, and require shorter hospital stays. These elements have boosted the acceptance of minimally invasive procedures, which limits the market's expansion.
The market for surgical sutures has been helped by the developing world's population's rapid demand for modern medical facilities. The rapid adoption of cutting-edge tools and technologies by the populace has propelled the market to new heights. Potential customers have been drawn to the sophisticated equipment that the healthcare system uses to suture wounds, which has helped the market generate sizable profits over time.
The market's expansion is hampered by the scarcity of qualified surgeons and the high price of surgical sutures. Another significant risk that could have a negative effect on the market's expansion is the availability of fake surgical sutures and the strict rules governing the approval and commercialization of surgical sutures.
COVID-19 had an adverse impact on the world economy. In 2020, many significant market participants noticed a decline. During the pandemic, the governments of many nations postponed elective surgeries in order to preserve healthcare resources for the COVID-19 emergency. Along with this, the imposition of lockdown forced a number of market participants and research organizations to delay their projects related to other chronic diseases. However, it is anticipated that the recent spread of the new COVID-19 strain in nations like the U.K., India, and others will further the trend of delaying operations and have an impact on the adoption of these devices.
The sutures segment is predicted to hold the largest market share in the estimated timeframe. This is a result of the enormous demand in the healthcare sector. Due to their affordability and ability to be used by the average person, surgical threads have been the preferred method of wound closure in many healthcare sectors.
Due to the increasing prevalence of various coronary artery diseases, arrhythmias, which increase the need for bypass surgeries, and increased use of surgical sutures, the cardiovascular surgery segment is anticipated to grow at the highest CAGR during the projection period. The most complicated and dangerous surgical procedures involve the cardiovascular system, making the best and most appropriate sutures necessary. Additionally, the increased use of cardiovascular surgeries as a result of an increase in patients with heart disorders increases market demand for surgical sutures.
North American region dominated the surgical suture market, and it is predicted to continue dominating the sector due to the presence of local and major players, the high cost of sutures relative to other regions, the favorable reimbursement environment, the expansion of government initiatives, and the sophistication of the healthcare system. The major drivers of North America's significant revenue share include domestically high income and technological advancements in this region.
During the forecast period, Asia Pacific is anticipated to experience the highest growth. This is due to the aging population that is more likely to undergo surgery, as well as an increase in government spending on the healthcare system to address the unmet needs in this area. Major markets in the Asia Pacific region include China, India, and Japan. Another important factor propelling the market in this region toward exponential growth is the rise of medical tourism in nations like India, Singapore, and Malaysia.
Some of the key players profiled in the Surgical Sutures Market include: Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, CPT Sutures, Deme TECH Corporation, Derma Sciences, Dolphin Sutures, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), Healthium MedTech, Integra Lifesciences, Internacional farmaceutica, Lotus Surgicals, Medtronic Plc , Mellon Medical B.V., Peter Surgical, Smith & Nephew, Stryker Corporation, Surgical Specialties Corporation, Sutcon Sutures, Vital Sutures and Zimmer Biomets.
In July 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) approval for the Vercise™ Neural Navigator 5 Software, which when used as part of the Vercise Genus™ Deep Brain Stimulation (DBS) Systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson's disease or essential tremor.
In August 2022, CONMED Corporation (announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. The transaction is being financed through the Company's existing credit facility.
In March 2022, B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates. With the full integration of Intermedt Medizin & Technik GmbH into the Group, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.